REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
06/02/2025
Back to search
Official data from USPTO
KESJEMO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
19
Latest update
06/03/2025
Classification
Registered
Trademark type
Word
Nice classes
5
Filing date
12/16/2019
Registration date
06/02/2020
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/02/2020
Last transaction
06/03/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
4
Owner type
99
Owner location
Stevenage, GB
Examiner
FAUCETTE,MAX CLIFFORD STE
Law office
L70
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Glaxo Group Limited
Glaxo Group Limited
Representatives
Elizabeth K. Rucki GlaxoSmithKline
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseasesblood disorderspaininflammationsepsisalopeciaobesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system related diseases and disorders; Vaccines
Publications
History of USPTO decisions and trademark events.
19 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/11/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/11/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/11/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
08/11/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
08/11/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
11/08/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/08/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/08/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/08/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
11/08/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
06/02/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/17/2020
PUBO
PUBLISHED FOR OPPOSITION
03/17/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/26/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/13/2020
DOCK
ASSIGNED TO EXAMINER
02/12/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/19/2019
NWAP
NEW APPLICATION ENTERED
12/19/2019
Continuous trademark protection
Get notified about every new filing that threatens KESJEMO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.